Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus

NCT02452528 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision to discontinue trial

Conditions

Chronic Hepatitis B

Interventions

DRUG: ARC-520
DRUG: Placebo
DRUG: Entecavir
DRUG: Tenofovir
DRUG: diphenhydramine

Sponsor

Arrowhead Pharmaceuticals